Rapport Therapeutics (RAPP) Selling, General & Administrative (2023 - 2026)
Rapport Therapeutics (RAPP) reported Selling, General & Administrative of $9.39 million for Q2 2026, up 37.8% from $6.82 million a year earlier but down 18.3% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rapport Therapeutics' Selling, General & Administrative came in at $36.85 million, up 37.6% year-over-year; for FY2025, it came in at $30.31 million, up 37.0% from FY2024.
- By year, Selling, General & Administrative came in at $22.12 million in FY2024 (+170.4%) and $8.18 million in FY2023.
- Five-year quarterly Selling, General & Administrative spans a low of $1.91 million in Q2 2023 and a high of $11.5 million in Q1 2026.
- Year over year, Selling, General & Administrative has now increased in each of the last nine quarters, with growth averaging 70.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 26.4% (Q3 2025) to 207.3% (Q3 2024).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.5 million (Q1 2026), $8.25 million (Q4 2025) and $7.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Rapport Therapeutics | 1.57 Bn | 1.57 Bn | - | 9.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.39 Mn |
| Mar 31, 2026 | 11.50 Mn |
| Dec 31, 2025 | 8.25 Mn |
| Sep 30, 2025 | 7.71 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Mar 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 6.32 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 1.98 Mn |
| Jun 30, 2023 | 1.91 Mn |
API Access
Rapport Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();